百利高 PRGO 深 沪
等待开盘 09-27 09:30:00 美东时间
21.445
+0.685
+3.30%
华盛通- 最 高21.45
- 今 开20.945
- 成交量 239.63万股
- 最 低 20.80
- 昨 收 20.76
- 总市值 29.59亿
- 52周最高 30.06
- 市盈率 静 --
- 换手率 1.74%
- 52周最低 20.515
- 委 比 95.15%
- 总股本 1.38亿
- 历史最高 206.589
- 量 比 0.92
- 振 幅 3.13%
- 历史最低 20.515
- 每 手 1
- 风险率 1.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Reported Earlier, President Trump Starting October 1st 2025 Imposes 100% Tariff On Branded Or Patented Pharmaceutical Products Unless Company Is Building Plant In America
https://truthsocial.com/@realDonaldTrump/posts/115267512131958759
09-26 13:43
'Local 210 Calls Out Pharmaceutical Manufacturer For Trying To Slash Workers' Benefits; Members Of Teamsters Local 210 Are On Strike At Perrigo Company's Bronx Manufacturing Facilities' - Teamsters
https://teamster.org/2025/09/perrigo-teamsters-in-new-york-launch-strike/
09-06 03:03
Perrigo to Attend Barclays 18th Annual Global Consumer Staples Conference
DUBLIN, Aug. 20, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and ...
08-20 19:30
Missed Opt-Out Deadline Could Cost Investors Millions In Perrigo Fraud Suit
Perrigo faces a legal battle over whether major investor Sculptor can exit a securities class action years after missing the opt-out deadline amid $1 billion restatements.
08-14 02:28
美股大行评级 | DoorDash获上调目标价从230美元升至300美元； 摩根大通上调Shopify目标价从115美元升至179美元
今日重点评级关注：HC Wainwright & Co.：维持FibroGen"买入"评级，目标价从10美元升至43美元；摩根大通：维持Cogent Biosciences"超配"评级，目标价从29美元升至30美元
08-08 09:34
JP Morgan Maintains Overweight on Perrigo, Lowers Price Target to $35
JP Morgan analyst Chris Schott maintains Perrigo (NYSE:PRGO) with a Overweight and lowers the price target from $38 to $35.
08-08 05:19
SA Asks: How could higher India tariffs impact drug stocks?
India is a major supplier of prescription drugs, over-the-counter medications, and pharmaceutical ingredients to the United States. Recently, President Trump announced he intends to impose a 25% tari...
08-08 01:00
Perrigo shares are trading lower after the company reported worse-than-expected Q2 financial results.
Perrigo shares are trading lower after the company reported worse-than-expected...
08-06 20:22
Perrigo Affirms FY2025 Adj EPS Guidance of $2.90-$3.10 vs $3.04 Est; Affirms FY2025 Sales Guidance of $4.373B-$4.504B vs $4.426B Est
Fiscal 2025 OutlookThe Company reaffirms its fiscal year 2025 outlook. Reported and organic net sales growth are expected towards the lower end of their respective ranges, primarily due to infant formula industry
08-06 18:43
Perrigo Q2 Adj. EPS $0.57 Misses $0.59 Estimate, Sales $1.056B Miss $1.082B Estimate
Perrigo (NYSE:PRGO) reported quarterly earnings of $0.57 per share which missed the analyst consensus estimate of $0.59 by 3.88 percent. This is a 7.55 percent increase over earnings of $0.53 per share from the same
08-06 18:31
